JP2010534227A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010534227A5 JP2010534227A5 JP2010517450A JP2010517450A JP2010534227A5 JP 2010534227 A5 JP2010534227 A5 JP 2010534227A5 JP 2010517450 A JP2010517450 A JP 2010517450A JP 2010517450 A JP2010517450 A JP 2010517450A JP 2010534227 A5 JP2010534227 A5 JP 2010534227A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon
- hydrogen atom
- oxime
- carbon bond
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims description 17
- 230000003078 antioxidant effect Effects 0.000 claims description 11
- 239000003963 antioxidant agent Substances 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 9
- QNTASHOAVRSLMD-GYKMGIIDSA-N n-[(8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]hydroxylamine Chemical class C1CC2=CC(=NO)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 QNTASHOAVRSLMD-GYKMGIIDSA-N 0.000 claims description 5
- 150000002923 oximes Chemical class 0.000 claims description 3
- 230000036620 skin dryness Effects 0.000 claims description 2
- 230000037393 skin firmness Effects 0.000 claims description 2
- 230000037303 wrinkles Effects 0.000 claims description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 12
- 239000002253 acid Substances 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 150000007513 acids Chemical class 0.000 claims 3
- -1 cholestane-3-one oxime Chemical class 0.000 claims 3
- 150000002148 esters Chemical class 0.000 claims 3
- 125000003544 oxime group Chemical group 0.000 claims 3
- 239000002537 cosmetic Substances 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 230000002335 preservative effect Effects 0.000 claims 2
- PESKGJQREUXSRR-UHFFFAOYSA-N 5beta-cholestanone Natural products C1CC2CC(=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 PESKGJQREUXSRR-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000000468 ketone group Chemical group 0.000 claims 1
- 230000036542 oxidative stress Effects 0.000 claims 1
- 230000009759 skin aging Effects 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 1
- NYOXRYYXRWJDKP-GYKMGIIDSA-N cholest-4-en-3-one Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 NYOXRYYXRWJDKP-GYKMGIIDSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0705426A FR2919180B1 (fr) | 2007-07-25 | 2007-07-25 | Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants |
| PCT/FR2008/001101 WO2009044010A2 (fr) | 2007-07-25 | 2008-07-24 | Utilisation d'au moins un dérivé oxime de la cholest-4-èn-3-one comme antioxydants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010534227A JP2010534227A (ja) | 2010-11-04 |
| JP2010534227A5 true JP2010534227A5 (enExample) | 2011-09-08 |
Family
ID=39167758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010517450A Pending JP2010534227A (ja) | 2007-07-25 | 2008-07-24 | 少なくとも１つのコレスト−４−エン−３−オンオキシム誘導体の酸化防止剤としての使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20100267680A1 (enExample) |
| EP (1) | EP2173198A2 (enExample) |
| JP (1) | JP2010534227A (enExample) |
| AU (1) | AU2008306838A1 (enExample) |
| BR (1) | BRPI0814580A2 (enExample) |
| CA (1) | CA2697125A1 (enExample) |
| FR (1) | FR2919180B1 (enExample) |
| MX (1) | MX2010000915A (enExample) |
| NZ (1) | NZ582646A (enExample) |
| RU (1) | RU2475052C2 (enExample) |
| WO (1) | WO2009044010A2 (enExample) |
| ZA (1) | ZA201000192B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2874923B1 (fr) * | 2004-09-07 | 2006-10-27 | Trophos Sa | Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation |
| FR2919182B1 (fr) * | 2007-07-25 | 2009-11-13 | Trophos | Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants |
| FR2979239A1 (fr) | 2011-08-25 | 2013-03-01 | Trophos | Liposome comprenant au moins un derive de cholesterol |
| WO2018090805A1 (en) * | 2016-11-15 | 2018-05-24 | Hong Kong Baptist University | Skin-protection composition containing dendrobium-based ingredients |
| CN108113996A (zh) * | 2016-11-29 | 2018-06-05 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种用于化学毒剂防护的水溶性皮肤防护剂及其制备方法和用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU487923A1 (ru) * | 1973-07-04 | 1975-10-15 | Ордена Трудового Красного Знамени Институт Кристаллографии Им.А.В.Шубникова | Стабильна жидкокристаллическа смесь |
| JPS61148111A (ja) * | 1984-12-21 | 1986-07-05 | Ichimaru Fuarukosu Kk | 発毛促進剤 |
| FR2581542B1 (fr) | 1985-05-07 | 1988-02-19 | Oreal | Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique |
| DE19834812A1 (de) * | 1998-08-01 | 2000-02-03 | Beiersdorf Ag | Verwendung von Sterolderivaten in kosmetischen und dermatologischen Zubereitungen zur Stärkung der Barrierefunktion der Haut |
| EP1601363B1 (fr) | 2003-03-11 | 2012-06-20 | Trophos | Application a titre de medicaments de derives de cholest-4-en-3- one, compositions pharmaceutiques les renfermant et nouveaux derives |
| FR2874923B1 (fr) * | 2004-09-07 | 2006-10-27 | Trophos Sa | Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation |
| US20060198809A1 (en) * | 2005-03-04 | 2006-09-07 | Woodridge Labs, Inc. | Gamma-amino butyric acid composition |
| FR2894968B1 (fr) | 2005-12-20 | 2008-02-22 | Trophos Sa | Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation |
| FR2898272B1 (fr) * | 2006-03-09 | 2008-07-04 | Trophos Sa | Utilisation de derives du 3,5-seco-4-nor-cholestrane pour l'obtention d'un medicament cytoprotecteur |
| FR2899108B1 (fr) * | 2006-03-31 | 2012-02-03 | Trophos | Utilisation de derives du cholest-4-en-3-one pour l'obtention d'un medicament cytoprotecteur |
| FR2914188B1 (fr) * | 2007-03-28 | 2012-06-22 | Trophos | Nouvelle composition a base d'oxime de cholest-4-en-3-one |
| FR2919182B1 (fr) * | 2007-07-25 | 2009-11-13 | Trophos | Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants |
| NZ584849A (en) * | 2007-10-30 | 2012-04-27 | Trophos | Novel composition for treating the side effects of anticancer treatments |
| FR2934596B1 (fr) * | 2008-07-30 | 2015-04-10 | Trophos | Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation |
| FR2940650B1 (fr) * | 2008-12-29 | 2017-01-27 | Trophos | Nouveaux derives d'oxime du 3,5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant,et procede de preparation |
-
2007
- 2007-07-25 FR FR0705426A patent/FR2919180B1/fr not_active Expired - Fee Related
-
2008
- 2008-07-24 NZ NZ582646A patent/NZ582646A/xx not_active IP Right Cessation
- 2008-07-24 WO PCT/FR2008/001101 patent/WO2009044010A2/fr not_active Ceased
- 2008-07-24 JP JP2010517450A patent/JP2010534227A/ja active Pending
- 2008-07-24 US US12/670,459 patent/US20100267680A1/en not_active Abandoned
- 2008-07-24 MX MX2010000915A patent/MX2010000915A/es active IP Right Grant
- 2008-07-24 EP EP08836563A patent/EP2173198A2/fr not_active Withdrawn
- 2008-07-24 BR BRPI0814580-6A2A patent/BRPI0814580A2/pt not_active IP Right Cessation
- 2008-07-24 RU RU2010106614/13A patent/RU2475052C2/ru not_active IP Right Cessation
- 2008-07-24 CA CA2697125A patent/CA2697125A1/fr not_active Abandoned
- 2008-07-24 AU AU2008306838A patent/AU2008306838A1/en not_active Abandoned
-
2010
- 2010-01-11 ZA ZA2010/00192A patent/ZA201000192B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI232110B (en) | Skin care composition | |
| JP2010534227A5 (enExample) | ||
| JP7426117B2 (ja) | 抗皮膚老化剤 | |
| JPH09505836A (ja) | 濃厚形態の生物学的活性を有するケイ素化合物の調製方法 | |
| JP2016527306A5 (enExample) | ||
| US11534380B2 (en) | Hair treatment method | |
| HUP0102923A2 (hu) | Neurológiai rendellenességek és hajhullás kezelésére szolgáló aza-heterociklusos vegyületek és ezeket a vegyületeket tartalmazó gyógyászati készítmények | |
| JP5751981B2 (ja) | 新規フェニルエタノイド配糖体及び皮膚化粧料 | |
| JPWO2003066100A1 (ja) | 発毛促進剤、経皮適用製剤及び発毛促進方法 | |
| RU2010106614A (ru) | Применение по меньшей мере одного производного оксима холест-4-ен-3-она в качестве антиоксиданта | |
| FR2976794A1 (fr) | Procede de coloration capillaire mettant en œuvre au moins un orthodiphenol, un sel de manganese ou de zinc, du peroxyde d'hydrogene, du (bi)carbonate, un agent alcalin et un sel de scandium | |
| EP3122329A1 (fr) | Composition cosmetique et/ou dermatologique pour la coloration de la peau | |
| JP3621341B2 (ja) | 頭髪用化粧料 | |
| WO2014099115A1 (en) | Collagen stimulators and their use in the treatment of skin | |
| WO2025150492A1 (ja) | 抗酸化組成物 | |
| JP2000290177A (ja) | 一酸化窒素捕捉剤及び老化防止化粧料 | |
| JP6076832B2 (ja) | メントール誘導体、並びにこれを用いた冷感剤、ｔｒｐｍ８活性化剤、冷感付与方法及びｔｒｐｍ８活性化方法 | |
| JP5265283B2 (ja) | 皮膚化粧料 | |
| EP2530087A3 (en) | Sequences of brachyspira, immunogenic composition, methods for preparation and use thereof | |
| FR2667241A1 (fr) | Humidificateur pour cuir chevelu et preparation externe pour la peau. | |
| JP2012171909A (ja) | 糖化阻害剤 | |
| KR101120660B1 (ko) | 알파-하이드록시 에시드 및 에테르계 계면활성제를포함하는 화장료 조성물 | |
| JP2001509129A (ja) | 皮膚の老化過程を抑制するための化粧品組成物及び方法 | |
| RU2743166C2 (ru) | Косметический способ | |
| WO2007057691A3 (en) | Therapeutic uses of steroidal compounds |